Articles by Disease (Melanoma)

Insulin-Like Growth Factor 2 - The Oncogene and its Accomplices

Journal: Current Pharmaceutical Design
Volume: 22
Page: 5948-5961
Author(s): Sonja M. Kessler, Johannes Haybaeck and Alexandra K. Kiemer

Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer Therapy

Journal: Current Pharmaceutical Design
Volume: 22
Page: 5943-5947
Author(s): Yi-Chao Zheng, Jin-Lian Ma, Ying Liu and Hong M. Liu

Targeting the EGF/HER Ligand-Receptor System in Cancer

Journal: Current Pharmaceutical Design
Volume: 22
Page: 5887-5898
Author(s): Azucena Esparís-Ogando, Juan Carlos Montero, Joaquín Arribas, Alberto Ocaña and Atanasio Pandiella

Determinants of Anti-Cancer Effect of Mitochondrial Electron Transport Chain Inhibitors: Bioenergetic Profile and Metabolic Flexibility of Cancer Cells

Journal: Current Pharmaceutical Design
Volume: 22
Page: 5998-6008
Author(s): Félix A. Urra, Boris Weiss-López and Ramiro Araya-Maturana

Exosomes: The Messengers of Health and Disease

Journal: Current Neuropharmacology
Volume: 15
Page: 157-165
Author(s): Allison L. Isola and Suzie Chen

Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases

Journal: Current Genomics
Volume: 18
Page: 75-92
Author(s): Chetan Kumar Jain, Hemanta Kumar Majumder and Susanta Roychoudhury

Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review

Journal: Current Genomics
Volume: 18
Page: 60-74
Author(s): Camila Hernandes, Ana Maria Soares Pereira and Patricia Severino